Relationship between cleaved L-selectin levels and the outcome of acute myeloid leukemia

Blood

Volumn 92, Issue 9, 1998, Pages 3115-3122

  Extermann, M ^b   Bacchi, M ^b   Monai, N ^b   Fopp, M ^b   Fey, M ^b   Tichelli, A ^b   Schapira, M ^b   Spertini, O ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

L SELECTIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLAST CELL; BLOOD LEVEL; CANCER SURVIVAL; CELL ADHESION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; LEUKOCYTE MIGRATION; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032213334     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.9.3115.421k31_3115_3122     Document Type: Article

References (63)

1. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76:301, 1994
2. Rosen SD, Bertozzi CR: The selectins and their ligands. Curr Opin Cell Biol 6:663, 1994
3. Tedder TF, Steeber DA, Chen A, Engel P: The selectins: Vascular adhesion molecules. FASEB J 9:866, 1995
4. Kansas GS: Selectins and their ligands - Current concepts and controversies. Blood 88:3259, 1996
5. Butcher EC, Picker LJ: Lymphocyte homing and homeostasis. Science 272:60, 1996
6. Girard J-P, Springer TA: High endothelial venules (HEVs): Specialized endothelium for lymphocytes migration. Immunol Today 16:449, 1995
7. Arbonés ML, Ord DC, Ley K, Ratech H, Maynard-Cury C, Otten G, Capon D J, Tedder TF: Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin (CD62L) deficient mice. Immunity 1:247, 1994
8. Gallatin WM, Weissman IL, Butcher EC: A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 304:30, 1983
9. Tedder TF, Steeber DA, Pizcueta P: L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites. J Exp Med 181:2259, 1995
10. Ley K, Bullard DC, Arbonés ML, Bosse R, Vestweber D, Tedder TF, Beaudet AL: Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J Exp Med 181:669. 1995
11. Spertini O, Cordey A-S, Monai N, Giuffrè L, Schapira M: P-selectin glycoprotein ligand-1 (PSGL-1) is a ligand for L-selectin on neutrophiis, monocytes and CD34+ hematopoietic progenitor cells. J Cell Biol 135:523, 1996
12. Wakheck B, Moore KL, Mcever RP, Kishimoto TK: Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1 - A mechanism that amplifies initial leukocyte accumulation on P-selectin in vitro. J Clin Invest 98:1081, 1996
13. Tu LL, Chen AJ, Delahunty MD, Moore KL, Watson SR, McEver RP, Tedder TF: L-selectin binds to P-selectin glycoprotein ligand-1 on leukocytes. J Immunol 157:3995, 1996
14. Alon R, Fuhlbrigge RL, Finger EB, Springer TA: Interactions through L-selectin between leukocytes and adherent leukocytes nucleate rolling adhesions on selectins and VCAM-1 in shear flow. J Cell Biol 135:849, 1996
15. Griffin JD, Spertini O, Ernst TJ, Belvin MP, Levine HB, Kanakura Y, Tedder TF: GM-CSF and other cytokines regulate surface expression of the leukocyte adhesion molecule-1 on human neutrophils, monocytes, and their precursors. J Immunol 145:576, 1990
16. Spertini O, Freedman AS, Belvin MP, Penta AC, Griffin JD, Tedder TF: Regulation of leukocyte adhesion molecule-1 (TQ1, Leu-8) expression and shedding by normal and malignant cells. Leukemia 5:300, 1991
17. Tedder TF, Penta AC, Levine HB, Freedman AS: Expression of the human leukocyte adhesion molecule, LAM1. Identity with the TQ1 and Leu-8 differentiation antigens. J Immunol 144:532, 1990
18. Spertini O, Callegari P, Cordey A-S, Hauert J, Joggi J, von Fliedner V, Schapira M: High levels of the shed form of L-selectin (sL-selectin) are present in patients with acute leukemia and inhibit blast cell adhesion to activated endothelium. Blood 84:1249, 1994
19. Spertini O, Luscinskas FW, Munro JM, Kansas GS, Griffin JD, Gimbrone MA, Tedder TF: Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. J Immunol 147:2565, 1991
20. Varki A: Selectin ligands - Will the real ones please stand up. J Clin Invest 99:158, 1997
21. Varki A: Selectin ligands. Proc Natl Acad Sci USA 91:7390, 1994
22. Giuffré L, Cordey A-S, Monai N, Tardy Y, Schapira M, Spertini O: Monocyte adhesion to activated aortic endothelium: Role of L-selectin and heparan sulfate proteoglycans. J Cell Biol 136:945, 1997
23. Lasky LA, Singer MS, Dowbenko D, Imai Y, Henzel WJ, Grimley C, Fennie C, Gillett N, Watson SR, Rosen SD: An endothelial ligand for L-selectin is a novel mucin-like molecule. Cell 69:927, 1992
24. Baumhueter S, Singer MS, Henzel W, Hemmerich S, Renz M, Rosen SD, Lasky LA: Binding of L-selectin to the vascular sialomucin CD34. Science 262:436, 1993
25. Alon R, Feizi T, Yuen C-T, Fuhlbrigge RC, Springer TA: Glycolipid ligands for selectins support leukocyte tethering and rolling under physiologic flow conditions. J Immunol 154:5356, 1995
26. Needham LK, Schnaar RL: The HNK-1 reactive sulfoglucuronyl glycolipids are ligands for L-selectin and P-selectin but not E-selectin. Proc Natl Acad Sci USA 90:1359, 1993
27. Spertini O: Circulating adhesion receptors in health and disease, in Paul L C, Issekutz T B (eds): Adhesion Molecules in Health and Disease, New York, NY. Dekker, 1997, p 123
28. Chen A, Engel P, Tedder TF: Structural requirements regulate endoproteolytic release of the L-selectin (CD62L) adhesion receptor from the cell surface of leukocytes. J Exp Med 182:519, 1995
29. Migaki GI, Kahn J, Kishimoto TK: Mutational analysis of the membrane-proximal cleavage site of L-selectin: Relaxed sequence specificity surrounding the cleavage site. J Exp Med 182:549, 1995
30. Kahn J, Ingraham R. Shirley F, Mikagi G, Kishimoto T: Membrane proximal cleavage of L-selectin: Identification of the cleavage site and a 6-kD transmembrane fragment of L-selectin. J Cell Biol 125:461, 1994
31. Schleiffenbaum B, Spertini O, Tedder TF: Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol 119:229, 1992
32. Spertini O, Schleiffenbaum B, White-Owen C, Ruiz P Jr, Tedder TF: ELISA for quantitation of L-selectin shed from leukocytes in vivo. J Immunol Methods 156:115, 1992
33. Stucki A, Cordey A-S, Monai N, de Flaugergues J-C Schapira M, Spertini O: Cleaved L-selectin in meningeal leukemia. Lancet 345:286, 1995
34. Benett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposed revised criteria for the classification of acute myeloid leukemia: A report of the French-American-British Cooperative Group. Ann Intern Med 103:620, 1985
35. Benett JM. Catovsky D, Daniel MT, Flandrin G, Gallon DAG, Gralnick HR, Sultan C: Proposals for the classification of the acute leukemias. Br J Haematol 33:451, 1976
36. Fopp M, Fey MF, Bacchi M, Cavalli F, Gmuer J, Jucky E, Schmid L, Tichelli A, Tobler, A, Tschopp L, Von Fliedner V, Gratwohl A, for the Leukaemia Group of the Swiss Group for Clinical Cancer Research (SAKK): Post-remission therapy of adult acute myeloid leukaemia: One cycle of high-dose versus standard-dose cytarabine. Ann Oncol 8:251, 1997
37. Cox DR, Snell EJ: Analysis of Binary Data (ed 2). London, UK, Chapman and Hall, 1988
38. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
39. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Rep 50:163, 1966
40. Cox DR: Regression models and life tables, J R Stat Soc B 34:187, 1972
41. Marubini E, Valsecchi MG: Analysing Survival Data From Clinical Trials and Observational Studies. Chichester, UK, Wiley, 1995
42. Jung SH, Wieand S. Cha SS: A statistic for comparing two correlated markers which are prognostic for time to an event, Stat Med 14:2217, 1995
43. Billström R, Nilsson P-G, Mitelman F: Chromosomes, Auer rods and prognosis in acute myeloid leukaemia. Eur J Haematol 40:273, 1988
44. Bernard P, Reiffers J, Lacombe F, Dachary D, Boisseau MR, Braustet A: A stage classification for prognosis in acute myelogenous leukemia based upon patients' age, bone marrow karyotype and clinical features. Scand J Haematol 32:429. 1984
45. Baudard M, Marie JP, Cadiou M, Viguie F, Zittoun R: Acute myelogenous leukaemia in the elderly: Retrospective study of 235 consecutive patients. Br J Haematol 86:82, 1994
46. San Miguel J-F, Ojeda E, Gonzalez M, Orfao A, Canizo MC, Sanchez J, Lopez-Borrasca A: Prognostic value of immunological markers in acute myeloblastic leukemia. Leukemia 3:108, 1989
47. Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, McIntyre OR, Frei Er: Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med 331:896, 1994
48. Mertelsmann R, Thaler HT, To L, Gee TS, McKenzie S, Schauer P, Friedman A, Arlin Z, Cirrincione C, Clarkson B: Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia. Blood 56:773, 1980
49. Estey E, Smith TL, Keating MJ, McCredie KB, Gehan EA, Freireich EJ: Prediction of survival during induction therapy in patients with newly diagnosed acute myeloblastic leukemia. Leukemia 3:257, 1989
50. Griffin JD, Davis R, Nelson DA, Davey FR, Mayer RJ, Schiffer C, McIntyre OR, Bloomfield CD: Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia. Blood 68:1232, 1986
51. Pedersen-Bjergaard J, Philip P, Olesen Larsen S, Jensen . Byrsting K: Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood 76:1083, 1990
52. Kantarjian HM, Keating MJ, Walters RS, McCredie KB, Freireich EJ: The characteristics and outcome of patients with late relapse acute myelogenous leukemia. J Clin Oncol 6:32, 1988
53. Buchner T, Heinecke A: The role of prognostic factors in acute myeloid leukemia. Leukemia 10:S28, 1996 (suppl 1)
54. Roberts WM, Estrov Z, Ouspenskaia MV, Johnston DA, McClain KL, Zipf TF: Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. N Engl J Med 336:317, 1997
55. Uckun FM, Kersey JH, Haake R, Weisdorf D, Nesbit ME, Ramsay NK: Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic. N Engl J Med 329:1296, 1993
56. Simonsson B: Treatment of minimal residual disease in acute myelogenous leukemia (AML): Focus on immunotherapeutic options. Leukemia 10:S44, 1996 (suppl 2)
57. Bradstock KF, Gottlieb DJ: Interaction of acute leukemia cells with the bone marrow microenvironment: Implications for control of minimal residual disease. Leuk Lymphoma 18:1, 1995
58. Assoian RK: Anchorage-dependent cell cycle progression. J Cell Biol 136:1, 1997
59. Ruoslahti E, Reed JC: Anchorage dependence, integrins. and apoptosis. Cell 77:477, 1994
60. Bradley L, Watson S, Swain S: Entry of naive CD4 T cells into peripheral lymph nodes requires L-selectin. J Exp Med 180:2401, 1994
61. Bishop JF, Matthews JP, Young GA, Szer J, Gillett A, Joshua D, Bradstock K, Enno A, Wolf MM, Fox R: A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood 87:1710, 1996
62. Mitus AJ, Miller KB, Schenkein DP, Ryan HF, Parsons SK, Wheeler C, Antin JH: Improved survival for patients with acute myelogenous leukemia. J Clin Oncol 13:560, 1995
63. Zittoun RA, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L, Leoni F, Damasio E, Visani G, Papa G: Autoiogous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 332:217. 1995